Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

BIOC

Biocept (BIOC)

Biocept Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIOC
DateTimeSourceHeadlineSymbolCompany
20/10/202321:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOCBiocept Inc
16/10/202323:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOCBiocept Inc
21/09/202322:00Business WireEnrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal MetastasesNASDAQ:BIOCBiocept Inc
08/09/202322:00Business WireBiocept Signs CNSide™ Licensing Agreement with Plus TherapeuticsNASDAQ:BIOCBiocept Inc
05/09/202322:00Business WireBiocept to Participate in the H.C. Wainwright Global Investment ConferenceNASDAQ:BIOCBiocept Inc
25/08/202322:00Business WireBiocept to Hold Business Update Conference Call on August 30, 2023NASDAQ:BIOCBiocept Inc
23/08/202306:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOCBiocept Inc
15/08/202306:05Business WireBiocept Reports Second Quarter 2023 Financial ResultsNASDAQ:BIOCBiocept Inc
14/08/202322:00Business WireBiocept’s CNSide™ Cerebrospinal Fluid Assay Featured in Two Oral Presentations at the 2023 SNO/ASCO CNS Cancer ConferenceNASDAQ:BIOCBiocept Inc
14/07/202308:15Business WireBiocept Announces the Passing of Board Chair M. Faye WilsonNASDAQ:BIOCBiocept Inc
22/06/202306:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOCBiocept Inc
21/06/202309:10Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BIOCBiocept Inc
21/06/202306:15Business WireBiocept Names Antonino Morales as President and Chief Executive OfficerNASDAQ:BIOCBiocept Inc
15/06/202306:05Business WireBiocept to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20, 2023NASDAQ:BIOCBiocept Inc
05/06/202322:00Business WireScientific Poster Presented at the 2023 ASCO Annual Meeting Highlights Performance of Biocept’s CNSide™ Versus CytologyNASDAQ:BIOCBiocept Inc
25/05/202320:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BIOCBiocept Inc
25/05/202310:39Business WireBiocept Announces Pricing of $5.0 Million Underwritten Public OfferingNASDAQ:BIOCBiocept Inc
23/05/202322:18Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:BIOCBiocept Inc
17/05/202322:00Business WireBiocept Announces One-for-Thirty Reverse Stock SplitNASDAQ:BIOCBiocept Inc
17/05/202306:12Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:BIOCBiocept Inc
15/05/202321:01Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:BIOCBiocept Inc
15/05/202320:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOCBiocept Inc
11/05/202306:05Business WireBiocept Reports First Quarter 2023 Financial ResultsNASDAQ:BIOCBiocept Inc
21/04/202322:31Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:BIOCBiocept Inc
21/04/202306:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOCBiocept Inc
18/04/202306:47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOCBiocept Inc
18/04/202306:10Business WireBiocept Reports 2022 Financial ResultsNASDAQ:BIOCBiocept Inc
18/04/202306:04Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:BIOCBiocept Inc
17/04/202322:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOCBiocept Inc
11/04/202306:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOCBiocept Inc
 Showing the most relevant articles for your search:NASDAQ:BIOC